(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma. - Wikidata - wikimedia - TriplyDB

(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.

(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.

http://www.wikidata.org/entity/Q42545669

about

Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative Approach CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma [68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experience Preclinical evaluation of [(68)Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo - a comparison to [(68)Ga]pentixafor.[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F]FDG and laboratory values.The Landscape of Clinical Trials Evaluating the Theranostic Role of PET Imaging in Oncology: Insights from an Analysis of ClinicalTrials.gov Database Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneity.Novel Noninvasive Nuclear Medicine Imaging Techniques for Cardiac Inflammation.An Overview of Multimodal Neuroimaging Using Nanoprobes.[177Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent.[68Ga]pentixafor for CXCR4 imaging in a PC-3 prostate cancer xenograft model - comparison with [18F]FDG PET/CT, MRI and ex vivo receptor expression.Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET.Targeting CXCR4 with [68Ga]Pentixafor: a suitable theranostic approach in pleural mesothelioma?PET and SPECT imaging of melanoma: the state of the art.Positron emission tomography of sodium glucose cotransport activity in high grade astrocytomas.CXCR4: A new player in vestibular schwannoma pathogenesis.Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma

P2860

Q30491728-E52761E6-AA8E-414B-9159-F688E8980980 Q33703097-B4695895-AD3B-4F1F-9C0B-E7B8F4C93329 Q36962582-81C99997-C888-42DF-A0B2-2BC2A7E6C6F0 Q37273212-699EC937-8BD8-4FEB-9FC4-932EE1CFB838 Q37541868-55B4EC5F-FE75-444E-98E0-FD01D08EA035 Q37541997-657DF5DA-6289-4F28-93E6-6231CD3639BC Q37701724-6F8C54B3-983D-4D10-A33C-120F0B360257 Q37703212-0C3F2037-EABD-4640-843D-202D7A68D98B Q39117742-B0EFEC0F-7513-499A-8F36-1E4563675DF4 Q41114242-3D5A0C5A-8136-4A4E-B515-2E641997826D Q47099762-51CA89E8-A901-4A5B-929E-77D4DB6F63D9 Q47100529-F77E7DFA-DC24-4CE9-A1DF-ED5DC840A71A Q47159998-CBEB43CC-D23E-4F76-96A2-BB3F532785E3 Q47868574-FC1E94DF-169F-4F7F-8E4F-A7760D7AC52C Q52662354-EFA4A684-8325-47CD-97D8-A155C96051C6 Q52668188-39A3140F-2113-4025-9CA4-B1D8DEDB864C Q52983236-56907726-FA8B-40DA-9E3B-3822AF5494F1 Q57160039-5460552A-244E-4035-906B-726CF3C3BB7C

P2860

(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.

http://www.wikidata.org/entity/Q42545669

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.

@en

type

label

(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.

@en

prefLabel

(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.

@en

P1433

Q42545669-35DB36B1-91C8-4E94-AF14-8AE7606BE5CA

P1476

Q42545669-E7F78E14-3B18-45EA-AD6B-AAB8122C5E12

P2093

Q42545669-0005108C-024B-4AC8-ACF2-CB2C985A4264

Q42545669-0A609FF0-A057-4038-A4A8-5F83F24037AB

Q42545669-12F9C8BC-1786-4268-A046-3316165A82CE

Q42545669-27FE4454-B3B6-48E6-B9F5-72E242FF4CCF

Q42545669-29D3B5A0-22A0-4E15-8A2A-ED0FA458CCD4

Q42545669-667EBFD9-F8B9-477F-8A32-C6D0D9F6C0B7

Q42545669-96C8E9A1-5F9F-4D20-8938-A323A2E42EC9

Q42545669-AECC11B3-29E9-45B1-BB04-7B10D95A5846

Q42545669-B84BF6AB-BC25-41C3-BDE3-FA9CC61ED1C6

Q42545669-DE2AA289-8DE5-451D-9B97-71281A3F83F1

P2860

Q42545669-0A45067B-99B0-4870-AF72-4BC6E99B3F3A

Q42545669-0AB45405-24A2-4077-9363-E533F0AFD8D5

Q42545669-0C84237D-4F93-4812-B5A6-129A9DD70865

Q42545669-0EB9B947-AB84-448B-9725-CC48496C3D0C

Q42545669-12937DA1-0C00-4DCE-8A79-9294A605513B

Q42545669-1BF96532-0663-40EE-BA00-6F9B2351328C

Q42545669-214B3AE9-7998-4907-B6AD-0F89F2F8AAA9

Q42545669-2C4C43CE-5886-4C3B-B9E0-8C7E2F7557F5

Q42545669-3BFC6A4D-F9A6-4DEF-8F3C-5DA89017FA33

Q42545669-450F52B6-9F97-464F-8B0F-2181E48B9ED7

P304

Q42545669-3B543185-9FE7-4281-839D-CF120A4746FA

P31

Q42545669-3A1420FA-24B4-4B07-9FE6-9EAE9AD4E481

P356

Q42545669-C1192D24-D61B-49C7-B33C-73F1D5E64F13

P433

Q42545669-BE47684B-2273-4B2E-AD5F-97BC45B2BF9B

P478

Q42545669-6CF69DE0-0E07-40E1-8221-B1E73C972827

P50

Q42545669-40EE29CE-E9F7-43D9-AA20-7E5AB7B08165

Q42545669-A0C4C65D-9F60-499F-82FB-6293A6ECAE1A

P577

Q42545669-B89F9E89-A9DB-498C-9471-E33296BA4564

P5875

Q42545669-BC8FD052-865D-4F80-A06C-262E85C8ACD6

P698

Q42545669-06326B84-B028-4F14-A52C-568D7F19C36D

P932

Q42545669-FF30A694-DD32-4F06-A28B-1D9E5890EFA6

P356

P1433

P1476

(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma

@en

P2093

Almuth F Kessler

http://www.w3.org/2001/XMLSchema#string

Camelia Maria Monoranu

http://www.w3.org/2001/XMLSchema#string

Constantin Lapa

http://www.w3.org/2001/XMLSchema#string

Hans-Jürgen Wester

http://www.w3.org/2001/XMLSchema#string

Irene Kleinlein

http://www.w3.org/2001/XMLSchema#string

Katharina Lückerath

http://www.w3.org/2001/XMLSchema#string

Ken Herrmann

http://www.w3.org/2001/XMLSchema#string

Mario Löhr

http://www.w3.org/2001/XMLSchema#string

Martina Rudelius

http://www.w3.org/2001/XMLSchema#string

Ralf-Ingo Ernestus

http://www.w3.org/2001/XMLSchema#string

P2860

The 2007 WHO classification of tumours of the central nervous system

Need for standardization of 18F-FDG PET/CT for treatment response assessments

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

CXCR4 over-expression and survival in cancer: a system review and meta-analysis

CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010.

Tumor-associated macrophages in glioblastoma multiforme-a suitable target for somatostatin receptor-based imaging and therapy?

Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging

In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.

Prospective Study of (68)Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and First Application in Glioma Patients.

Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway.

P304

428-434

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/THNO.13986

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Andreas K. Buck

Thomas Linsenmann

P577

2016-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

292176724

http://www.w3.org/2001/XMLSchema#string

P698

26909116

http://www.w3.org/2001/XMLSchema#string

P932

4737728

http://www.w3.org/2001/XMLSchema#string